Trinity Biotech (TRIB) Total Debt (QoQ) (2009 - 2024)
Trinity Biotech (TRIB) Total Debt (QoQ) (2009 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Trinity Biotech | 23,520.00 | -5.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 10.46% |
| Sep 30, 2024 | -0.32% |
| Jun 30, 2024 | 12.01% |
| Mar 31, 2024 | 47.76% |
| Dec 31, 2023 | -1.10% |
| Sep 30, 2023 | -0.56% |
| Jun 30, 2023 | -18.53% |
| Mar 31, 2023 | 10.56% |
| Dec 31, 2022 | 0.10% |
| Sep 30, 2022 | -0.37% |
| Jun 30, 2022 | -40.97% |
| Mar 31, 2022 | 251,245.16% |
| Jun 30, 2012 | -57.14% |
| Mar 31, 2012 | -35.19% |
| Dec 31, 2011 | -28.95% |
| Sep 30, 2011 | -13.64% |
| Jun 30, 2011 | 1.15% |
| Mar 31, 2011 | 7.41% |
| Dec 31, 2010 | -38.87% |
| Sep 30, 2010 | -9.86% |